Factors | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Hazard ratio (95% confidence interval) | p-value | Hazard ratio (95% confidence interval) | p-value | |
Overall Survival | ||||
Female gender | 0.674 (0.431–1.052) | 0.083 | 0.677 (0.316–1.449) | 0.316 |
Tumour size ≤5cm | 0.473 (0.214–1.045) | 0.064 | 0.797 (0.285–2.23) | 0.666 |
Renal vascular origin | 0.458 (0.237–0.886) | 0.02 | 0.49 (0.135–1.777) | 0.278 |
Low grade | 0.164 (0.05–0.533) | 0.003 | 0.236 (0.067–0.837) | 0.025 |
Non-metastatic disease | 0.271 (0.141–0.521) | 0.001 | 0.772 (0.224–2.652) | 0.681 |
Disease free Survival | ||||
Female gender | 0.351 (0.164–0.752) | 0.007 | 0.123 (0.012–1.272) | 0.079 |
Tumour size ≤5cm | 0.807 (0.395–1.649) | 0.556 | 0.818 (0.079–8.403)) | 0.866 |
Renal vascular origin | 0.523 (0.153–1.786) | 0.301 | 0.203 (0.024–1.739) | 0.146 |
Low grade | 0.012 (0.000–2.694) | 0.109 | 0.005 (0.000–3.412) | 0.654 |
Non-metastatic disease | 0.125 (0.039–0.399) | 0.001 | 0.477 (0.026–8.62) | 0.616 |